Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Resmed Inc (RMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 15,453,033
  • Shares Outstanding, K 142,740
  • Annual Sales, $ 2,340 M
  • Annual Income, $ 315,590 K
  • 36-Month Beta 0.89
  • Price/Sales 6.51
  • Price/Cash Flow 24.27
  • Price/Book 7.40

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 0.80
  • Number of Estimates 4
  • High Estimate 0.89
  • Low Estimate 0.73
  • Prior Year 0.66
  • Growth Rate Est. (year over year) +21.21%

Price Performance

See More
Period Period Low Period High Performance
1-Month
102.75 +5.36%
on 08/03/18
109.97 -1.55%
on 07/20/18
-0.86 (-0.79%)
since 07/13/18
3-Month
100.57 +7.65%
on 05/29/18
109.97 -1.55%
on 07/20/18
+6.11 (+5.98%)
since 05/14/18
52-Week
72.44 +49.45%
on 08/15/17
109.97 -1.55%
on 07/20/18
+34.64 (+47.05%)
since 08/14/17

Most Recent Stories

More News
Shares of Transenterix Inc Rank the Highest in Terms of Relative Performance in the Health Care Equipment Industry (TRXC, CSII , RMD , DHR , IART )

We looked at the Health Care Equipment industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We...

RMD : 108.26 (+1.43%)
TRXC : 4.33 (-9.03%)
CSII : 37.25 (+0.03%)
Resmed Inc Falls 4.46% on Heavy Volume: Watch For Potential Rebound

Resmed Inc (NYSE:RMD) traded in a range yesterday that spanned from a low of $102.75 to a high of $106.48. Yesterday, the shares fell 4.5%, which took the trading range below the 3-day low of $104.88...

RMD : 108.26 (+1.43%)
ResMed (RMD) Q4 Earnings & Sales Beat on Overall Growth

ResMed (RMD) sees solid contributions from domestic and international businesses in Q4.

CHE : 317.17 (+0.57%)
RMD : 108.26 (+1.43%)
ALGN : 368.66 (+1.76%)
ISRG : 529.00 (+1.66%)
ResMed (RMD) Q4 Earnings and Revenues Top Estimates

ResMed (RMD) delivered earnings and revenue surprises of 5.56% and 1.18%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

RMD : 108.26 (+1.43%)
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2018

--Net income increased by 8%; non-GAAP net income up 24%

RMD : 108.26 (+1.43%)
Why Earnings Season Could Be Great for ResMed (RMD)

ResMed (RMD) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

RMD : 108.26 (+1.43%)
Medical Product Earnings Lineup for Aug 2: ABC, BDX & More

Strong R&D focus is likely to be the key driver of the Medical Product space in Q2.

CERN : 64.32 (+0.06%)
ABC : 84.43 (+1.65%)
SYK : 166.21 (+0.06%)
BDX : 250.40 (+0.87%)
RMD : 108.26 (+1.43%)
ISRG : 529.00 (+1.66%)
Can Overall Growth Drive ResMed's (RMD) Q4 Earnings?

ResMed (RMD) is likely to keep its winning streak alive with a gain from strong performances on the domestic as well as global front in Q4.

BIOS : 2.88 (+1.41%)
RMD : 108.26 (+1.43%)
BAX : 70.71 (unch)
ALGN : 368.66 (+1.76%)
Boston Scientific (BSX) Q2 Earnings: Is a Beat in Store?

Boston Scientific (BSX) expects to consistently gain from impressive growth across all business lines and geographies.

SYK : 166.21 (+0.06%)
HSIC : 78.25 (+0.55%)
BSX : 33.70 (+1.20%)
RMD : 108.26 (+1.43%)
Will 5 Elements Drive Quest Diagnostics (DGX) Q2 Earnings?

Per Quest Diagnostics (DGX), growing strength of partnerships with health care leaders and strategic acquisitions are creating growth prospects for the top and bottom-line growth.

SYK : 166.21 (+0.06%)
DGX : 108.65 (+0.21%)
MCK : 126.68 (+0.52%)
RMD : 108.26 (+1.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade RMD with:

Business Summary

ResMed Inc. is a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions....

See More

Key Turning Points

2nd Resistance Point 109.83
1st Resistance Point 109.05
Last Price 108.26
1st Support Level 107.11
2nd Support Level 105.95

See More

52-Week High 109.97
Last Price 108.26
Fibonacci 61.8% 95.63
Fibonacci 50% 91.21
Fibonacci 38.2% 86.78
52-Week Low 72.44

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar